CD44 and cancer: These platforms can be used to screen the activity of drugs on cancer cell invasion (whose evolution is dependent on the interaction between CD44-HA), leading to the achievement of consistent data that supports the further evaluation of selected drugs in the pipeline that leads to their use in the clinical practice.